Picture of Aequus Pharmaceuticals logo

AQS — Aequus Pharmaceuticals News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Aequus Announces Expansion Of Market Opportunity For Its Long Acting Anti-Nausea Transdermal Patch

July 19 (Reuters) - Aequus Pharmaceuticals Inc  AQS.V :
    * AEQUUS ANNOUNCES EXPANSION OF MARKET OPPORTUNITY FOR ITS
LONG
ACTING ANTI-NAUSEA TRANSDERMAL PATCH
    * AEQUUS - PLANS TO LAUNCH AQS1303 IN COUNTRIES WHERE
ORIGINAL
ORAL FORM APPROVED, ACCELERATED PATH TO APPROVAL MAY EXIST FOR
REFORMULATED PRODUCTS
    * AEQUUS PHARMACEUTICALS - FOLLOWING REVIEW BY MHRA &
COMMISSION
ON CHM IN JUNE 2018, XONVEA EXPECTED TO BE AVAILABLE IN UK LATER
IN 2018

Source text for Eikon:  ID:nGNXb96dMC 
Further company coverage:  AQS.V 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Aequus Pharmaceuticals

See all news